Think of Fiasp as Faster-Acting NovoLog

December 2017

Fiasp (FEE-asp, insulin aspart) will be a new "ultrafast-acting" mealtime insulin for adults with diabetes.

Think of Fiasp as similar to NovoLog. They're both insulin aspart...but Fiasp has an additive to speed absorption.

Use its brand name as a reminder of what Fiasp is..."faster-acting insulin aspart."

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Practice Ensure Your Patients Get In-Date Meds
Vaccines Be Aware of the Differences Between Shingrix and Zostavax
Insulin Think of Fiasp as Faster-Acting NovoLog
Medication Errors Remember "One Shake, Two Shake" With Reconstituted Oral Meds
Supplements Watch for Patients Picking Up Cinnamon for Diabetes
Constipation Symproic Will Join Movantik and Relistor for Opioid-Induced Constipation
Medication Errors Keep Oral Cyclosporine Products Straight
Cardiology Help Your Spironolactone and Eplerenone Patients Take Their Med Safely
Acne Oral Antibiotics for Acne Should Usually Be Limited to 3 to 4 Months
Gastroenterology Be Familiar With Meds That Are Held Before Colonoscopy
Sickle Cell Disease Endari Will Be a New Specialty Med for Sickle Cell Disease